National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 30743-30744 [2019-13681]
Download as PDF
Federal Register / Vol. 84, No. 124 / Thursday, June 27, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jspears on DSK30JT082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Respiratory Sciences.
Date: July 17, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Eugene Carstea, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4130,
MSC 7818, Bethesda, MD 20892, (301) 408–
9756, carsteae@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Skeletal
Muscle Biology.
Date: July 17, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Maria Nurminskaya, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, Bethesda, MD 20892, (301) 435–1222,
nurminskayam@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Acute Brain
Injury.
Date: July 19, 2019.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
VerDate Sep<11>2014
20:15 Jun 26, 2019
Jkt 247001
Topic: Vision Imaging, Bioengineering and
Low Vision Technology Development.
Date: July 22–23, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Washington, DC, 923
16th Street NW, Washington, DC 20006.
Contact Person: Susan Gillmor, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive Bethesda, MD 20892, 240–
762–3076, susan.gillmor@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
19–026: Clinical and Biological Measures of
TBI-Related Dementia.
Date: July 22, 2019.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, BDCN IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 5210, MSC 7846,
Bethesda, MD 20892, (301) 435–1246,
edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
19–026: Clinical and Biological Measures of
TBI-Related Dementia.
Date: July 22, 2019.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Room 5211
Bethesda, MD 20892, 301–760–8207,
schauweckerpe@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodegenerative Diseases.
Date: July 22, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, RKL II,
6701 Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7846, Bethesda, MD 20892–7846, 301–
827–7238, zhaow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
19–030, NATBI CWOW, Neuropathological
Assessment of TBI-related
Neurodegeneration and Neurocognitive
Decline—Center Without Walls.
Date: July 22, 2019.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
30743
Contact Person: Alexander Yakovlev,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206,
MSC 7846, Bethesda, MD 20892–7846, 301–
435–1254, yakovleva@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Adult and Child Psychopathology.
Date: July 22, 2019.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Benjamin Greenberg
Shapero, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3182, Bethesda, MD 20892,
shaperobg@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 21, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13675 Filed 6–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Resource-Related
Research Projects (R24).
Date: July 17, 2019.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\27JNN1.SGM
27JNN1
30744
Federal Register / Vol. 84, No. 124 / Thursday, June 27, 2019 / Notices
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: David C. Chang, Ph.D.,
Scientific Review Officer Scientific Review
Program DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, MSC 9823 Rockville, MD 20852
301–594–4218, changdac@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 21, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13681 Filed 6–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meeting
jspears on DSK30JT082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Advancing Translational Sciences
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: September 19, 2019.
Closed: 9:00 a.m. to 10:30 a.m.
Agenda: To discuss internal operations,
review and evaluate grant applications.
Place: Porter Neuroscience Research
Center, National Institutes of Health,
Building 35A, Conference Room 620/630, 35
Convent Drive, Bethesda, MD 20892.
VerDate Sep<11>2014
20:15 Jun 26, 2019
Jkt 247001
Open: 11:00 a.m. to 4:30 p.m.
Agenda: Report from the Institute Director
and other staff.
Place: Porter Neuroscience Research
Center, Building 35A, Conference Room 620/
630, 35 Convent Drive, Bethesda, MD 20892.
Time: 9:00 a.m. to 4:30 p.m.
Agenda: To discuss internal operations,
review and evaluate grant applications.
Place: Porter Neuroscience Research
Center, National Institutes of Health,
Building 35A, Conference Room 620/630, 35
Convent Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: June 21, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13678 Filed 6–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Cures Acceleration
Network Review Board.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Cures Acceleration
Network Review Board.
Date: September 19, 2019.
Time: 11:00 a.m. to 4:30 p.m.
Agenda: Report from the Institute Director.
Place: Porter Neuroscience Research
Center, National Institutes of Health,
Building 35A, Conference Room 620/630, 35
Convent Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: June 21, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13679 Filed 6–26–19; 8:45 am]
BILLING CODE 4140–01–P
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Notice of Advisory Council on Historic
Preservation Quarterly Business
Meeting
Advisory Council on Historic
Preservation.
ACTION: Notice of Advisory Council on
Historic Preservation quarterly business
meeting.
AGENCY:
Notice is hereby given that
the Advisory Council on Historic
Preservation (ACHP) will have its next
quarterly meeting on Wednesday, July
10, 2019. The meeting will take place at
the Smithsonian Castle, Visitor Center
in the Great Hall, 1000 Jefferson Avenue
NW, Washington, DC, starting at 8:30
a.m.
SUMMARY:
The quarterly meeting will take
place on Wednesday, July 10, 2019
starting at 8:30 a.m.
ADDRESSES: The meeting will take place
in the Great Hall at the Smithsonian
Castle, 1000 Jefferson Avenue NW,
Washington, DC.
FOR FURTHER INFORMATION CONTACT:
Tanya DeVonish, 202–517–0205,
tdevonish@achp.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Council on Historic
Preservation (ACHP) is an independent
federal agency that promotes the
preservation, enhancement, and
sustainable use of our nation’s diverse
historic resources, and advises the
President and the Congress on national
historic preservation policy. The goal of
the National Historic Preservation Act
(NHPA), which established the ACHP in
1966, is to have federal agencies act as
responsible stewards of our nation’s
resources when their actions affect
historic properties. The ACHP is the
only entity with the legal responsibility
to encourage federal agencies to factor
historic preservation into their decision
making. For more information on the
ACHP, please visit our website at
www.achp.gov.
DATES:
E:\FR\FM\27JNN1.SGM
27JNN1
Agencies
[Federal Register Volume 84, Number 124 (Thursday, June 27, 2019)]
[Notices]
[Pages 30743-30744]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13681]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Resource-Related Research
Projects (R24).
Date: July 17, 2019.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 30744]]
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: David C. Chang, Ph.D., Scientific Review Officer
Scientific Review Program DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC
9823 Rockville, MD 20852 301-594-4218, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: June 21, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-13681 Filed 6-26-19; 8:45 am]
BILLING CODE 4140-01-P